Skip to main content
RF

Rhea Fertility

Rhea Fertility offers an integrated global reproductive health ecosystem that connects a network of fertility clinics with a proprietary AI-powered technology platform. This platform streamlines the fertility journey for intended parents by improving patient outcomes and accelerating service delivery through advanced diagnostics and mental health support.

Singapore, Singapore16700+ followers
Updated 2 months ago

Funding

Funding not disclosed

TC
Funding rounds are not available yet.

Founders

Product

Problem

The fertility market is fragmented, creating significant barriers for intended parents seeking to build their families. This fragmentation leads to disjointed patient experiences and hinders access to comprehensive reproductive health services across different regions.

Solution

Rhea Fertility provides an integrated global reproductive health ecosystem designed to streamline the fertility journey for intended parents. The company connects a network of owned and partner clinics, branded as GenPrime, with its proprietary technology platform, Rhea Labs. Rhea Labs leverages AI and data analytics to enhance patient outcomes and accelerate service delivery. Through strategic acquisitions, such as Embryonics for AI diagnostic tools and Tilly for mental health support, Rhea is building a comprehensive offering that addresses multiple facets of reproductive care. The company also facilitates gamete exchange through RheaX, a joint venture aimed at improving gamete matching and transfer processes.

Target Audience

The primary target audience includes intended parents navigating fertility treatments globally, as well as fertility clinics and healthcare providers seeking to integrate advanced technology and comprehensive services into their offerings.

Features

  • Global network of owned and partner fertility clinics (GenPrime)
  • Rhea Labs: Integrated technology platform utilizing AI and data analytics for patient outcome improvement and service delivery acceleration.
  • Embryonics acquisition: Integration of AI-powered diagnostic tools to enhance fertility treatment processes.
  • Tilly acquisition: Incorporation of digital mental health tools and treatment tracking for infertility patients.
  • RheaX: Global gamete exchange platform for improved gamete matching and transfers, developed in partnership with Baylor College of Medicine.
  • Patient journey management tools integrated within the clinic network.
  • Collaboration with Baylor College of Medicine for reproductive health research initiatives.
This profile is AI-generated and may contain inaccuracies.